Shenzhen’s LWPOCT Secures RMB 100 Million in Series A Round for CDMO Expansion
Shenzhen-based medical devices and reagents manufacturer Shenzhen Living Water POCT Co., LTd (LWPOCT) has reportedly...
Finance
Hangzhou Tongee Medical Closes RMB 100 Million Series B Round for Gastric Bypass Stent
Hangzhou Tongee Medical Technology Co., Ltd, a Chinese device maker specializing in metabolic disease treatments,...
Joincare Pharmaceutical Plans USD 300-400 Million GDR Issue for Global Expansion
China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) announced plans to issue Global Depository...
MegaRobo Secures USD 300 Million in Series C Round Led by Goldman Sachs
Beijing-based MegaRobo Technologies, a company applying robotics and artificial intelligence (AI) in the life sciences...
WuXi AppTec Faces Shareholder Divestment of Up to 3% Stake
China-based Contract Research Organization (CRO) WuXi AppTec Co., Ltd (SHA: 603259, HKG: 2359) has disclosed...
Gritgen Therapeutics Secures Hundreds of Millions in A-Round Financing for Gene Therapy Pipeline
Gritgen Therapeutics, a leading gene therapy drug developer based in Suzhou, has announced the successful...
Shenzhen-Based Pregbio Raises Funds for Non-Invasive Prenatal Gene Detection
Pregbio, a Shenzhen-based non-invasive prenatal gene detection company, has reportedly raised an undisclosed amount of...
Exegenesis Bio Secures Multi-Million Dollar Series B Financing for Gene Therapy Pipeline
Exegenesis Bio Inc., a leading gene therapy company, has successfully completed a Series B financing...
Asymchem Laboratories Secures RMB 2.31 Billion Private Placement with Hill House Capital Subscription
Asymchem Laboratories (Tianjin) Co., Ltd, a renowned Contract Development and Manufacturing Organization (CDMO) based in...
LanssonPharm Secures Series A Funding to Accelerate CNS Drug Development
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...